Chief Medical Officer · Terns Pharmaceuticals, Inc. · Terns Pharmaceuticals, Inc. — Stock Option (Right to Buy)
Side
A
Value
—
Shares
112.5K
Price
—
Executed
Jan 14, 2026
Disclosed
Jan 16, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jan 14 executedJan 16, 2026 disclosed
TERN · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Terns Pharmaceuticals, Inc. — Stock Option (Right to Buy)
Ticker
TERN
Shares
112.5K
Price per share
$0
Execution date (reported)
Jan 14, 2026
Owned after transaction
112.5K shares
Days from execution to publication
2
What this establishes
Kuriakose Emil filed this Form 4 reporting a grant or award of TERN on Jan 14, 2026. It became public on Jan 16, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Medical Officer
Kuriakose Emilcik:0001892413
Issuer
Terns Pharmaceuticals, Inc.cik:0001831363
Revision history · 0
No field has changed since this record was first ingested.
Company events
No records
No material filings recorded for this issuer.
Source error
Price history for TERN is unavailable.
An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.
